LONDON, Aug. 4, 2025 /PRNewswire/ — A new study from revenue intelligence leader Ebsta finds that the biggest differentiator between top-performing sales teams and the rest isn’t more meetings or a bigger pipeline, it’s qualification discipline.
The 2025 Ebsta Sales Qualification Report, analyzing over 655,000 B2B opportunities totaling $48 billion, reveals that well-qualified deals are 6.3x more likely to close than poorly qualified ones, and close 21.6% faster on average.
“Qualification isn’t a one-time gate,” said Guy Rubin, CEO of Ebsta. “It’s a dynamic, ongoing process that shapes every stage of the deal. The best teams don’t just qualify early, they qualify continuously.”
Despite the clear upside, only 36% of deals that pass Discovery include both a qualification score and supporting notes, leading to forecasting blind spots, longer sales cycles, and wasted seller effort.
Key Findings:
“The goal of qualification isn’t to weed out bad deals,” said Warren Zenna, Founder of The CRO Collective. “It’s to unify the org around what a good deal actually looks like. That clarity drives alignment, confidence, and predictable growth.”
The report features insights from sales leaders, including Ollie Sharpe (CRO, trumpet), who notes:
“When your champion shares a sales room internally at least twice, the sales cycle shortens by an average of 15%.”
A Wake-Up Call for CROs and RevOps Leaders
The report is particularly relevant for Chief Revenue Officers, RevOps teams, and sales trainers looking to improve quota attainment and pipeline efficiency in a resource-constrained environment.
Ebsta recommends reinforcing MEDDPICC or similar methodologies across all stages, not just early discovery, and using qualification rigor as a leading indicator for forecasting health and coaching effectiveness.
Get Early Access to the Full Report
Sales, RevOps, and GTM leaders can get early access to the full 2025 Sales Qualification Report by signing up for the Ebsta newsletter.
About Ebsta
Ebsta is a revenue intelligence platform that helps B2B sales teams drive predictable growth by analyzing activity, engagement, and CRM data to surface deal risk, improve forecast accuracy, and accelerate pipeline velocity.
Learn more at www.ebsta.com
Media Contact:
Graham Smith
399093@email4pr.com
+44 2030025800
SOURCE Ebsta Ltd
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…